Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA approves Calquence for CLL and SLL

Nov. 22, 2019

New compounds for cancer patented by Hinova Pharmaceuticals

Nov. 22, 2019

Chinese researchers identify BRD4 inhibitors

Nov. 22, 2019

Incyte discloses adenosine A2A and A2B receptor antagonists

Nov. 22, 2019

University of Texas System discloses PTPN11 inhibitors

Nov. 22, 2019

New cannabinoid receptor modulators revealed in recent patent

Nov. 22, 2019

CtBP2 affects multiple pathways in acute kidney injury

Nov. 22, 2019

First-in-human trial with the triple gene construct INXN-4001 for treatment of heart failure

Nov. 22, 2019

Phase II data on AG-10 in ATTR cardiomyopathy support entry into phase III

Nov. 22, 2019

ALG-055009: a THR-beta agonist for treating NASH

Nov. 22, 2019

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...